During the last session, Phathom Pharmaceuticals Inc (NASDAQ:PHAT)’s traded shares were 1.9 million, with the beta value of the company hitting 0.08. At the end of the trading day, the stock’s price was $2.29, reflecting an intraday loss of -4.58% or -$0.11. The 52-week high for the PHAT share is $19.71, that puts it down -760.7 from that peak though still a striking -3.93% loss since the share price plummeted to a 52-week low of $2.38. The company’s market capitalization is $159.87M, and the average trade volume was 1.39 million shares over the past three months.
Phathom Pharmaceuticals Inc (PHAT) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.25. PHAT has a Sell rating from 2 analyst(s) out of 10 analysts who have looked at this stock. 2 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 6 recommend a Buy rating for it.
Phathom Pharmaceuticals Inc (NASDAQ:PHAT) trade information
Phathom Pharmaceuticals Inc (PHAT) registered a -4.58% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -4.58% in intraday trading to $2.29, hitting a weekly high. The stock’s 5-day price performance is -31.85%, and it has moved by -46.12% in 30 days. Based on these gigs, the overall price performance for the year is -78.87%.
The consensus price target of analysts on Wall Street is $18, which implies an increase of 87.28% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $18 and $18 respectively. As a result, PHAT is trading at a discount of -686.03% off the target high and -686.03% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 12.50%. While earnings are projected to return 40.05% in 2025.
PHAT Dividends
Phathom Pharmaceuticals Inc is due to release its next quarterly earnings in June. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 7.46 million shares, is of MEDICXI VENTURES MANAGEMENT (JERSEY) LTD’s that is approximately 12.7473% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $76.89 million.
Also, the Mutual Funds coming in first place with the largest holdings of Phathom Pharmaceuticals Inc (PHAT) shares are AIM Intl Mutual Fd.s -Invesco Global Fd. and Prudential Sector Funds, Inc.-PGIM Jennison Health Sciences Fund . Data provided on Jan 31, 2025 indicates that AIM Intl Mutual Fd.s -Invesco Global Fd. owns about 1.98 shares. This amounts to just over 2.83 percent of the company’s overall shares, with a $4.52 million market value. The same data shows that the other fund manager holds slightly less at 1.78, or about 2.55% of the stock, which is worth about $4.08 million.
